LAZR - AJRD AJIO NK and LAZR among premarket gainers

EyeGate Pharmaceuticals (EYEG) +87% as it acquires Panoptes Pharma.NantKwest (NK) +32% as its partner, ImmunityBio, achieves primary endpoint in bladder cancer study.RealPage (RP) +31% as Thoma Bravo has agreed to buy the company for $9.6B.China Customer Relations Centers (CCRC) +27%.Aerojet Rocketdyne Holdings (AJRD) +27% as Lockheed Martin buying the company in $4.4B deal.Agios Pharmaceuticals (AGIO) +26% on announcing an agreement to sell its oncology programs to Servier.AIM ImmunoTech (AIM) +26% as FDA grants Orphan Drug designation to its drug Ampligen (rintatolimod).Corbus Pharmaceuticals Holdings (CRBP) +20%.Clovis Oncology (CLVS) +18% as its Rubraca® met the primary endpoint.500.com (WBAI) +19% on appointing new CEO and COOFuel Tech (FTEK) +14%.Blueknight Energy Partners (BKEP) +13% after agreeing to sell its crude oil terminalling, pipeline and trucking business segments for ~$162M.Cleveland BioLabs (CBLI) +14% after company issues shareholder letter.Venus Concept (VERO) +14%.Ra Medical Systems (RMED) +13%.Barnes & Noble Education (BNED) +13% after partnering with Fanatics.908 Devices (MASS) +12%.Polar Power (POLA) +11%.Aqua Metals (AQMS) +9%.RADA Electronic Industries (RADA)

For further details see:

AJRD, AJIO, NK and LAZR among premarket gainers